Registry-based Stroke in Tunisia
Launched by UNIVERSITY OF MONASTIR · Apr 5, 2022
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The "Registry-based Stroke in Tunisia" clinical trial is focused on understanding how common strokes are in the emergency department and determining which patients might be eligible for a treatment called thrombolysis. Thrombolysis is a procedure that can help dissolve blood clots that cause certain types of strokes, allowing for better recovery. This study aims to gather valuable information that could improve stroke care in Tunisia.
If you or someone you know is experiencing symptoms of a stroke, they may be eligible to participate in this trial. The trial is open to individuals aged between 65 and 74 years, and there are no restrictions based on gender. The only requirement is that participants must agree to take part in the study. Those who join can expect to be assessed for their stroke symptoms and receive appropriate care while contributing to important research that could benefit future stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with stroke symptoms.
- Exclusion Criteria:
- • Refusal of inclusion
About University Of Monastir
The University of Monastir, a prominent educational and research institution in Tunisia, is dedicated to advancing medical and clinical research through its innovative programs and collaborations. With a strong emphasis on improving healthcare outcomes, the university actively sponsors clinical trials that explore new therapeutic approaches and enhance patient care. Leveraging its state-of-the-art facilities and a diverse team of experienced researchers and clinicians, the University of Monastir aims to contribute significantly to the global body of medical knowledge while fostering a culture of scientific inquiry and excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Monastir, , Tunisia
Patients applied
Trial Officials
Nouira Semir, Professor
Principal Investigator
University of Monastir
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials